Parlodel

Product NDC: 30698-201
11-digit product format: 306980201
Labeler code: 30698
Product ID: 30698-201_0bcbd9ce-2476-4426-bbbe-45828e72dc28
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: bromocriptine mesylate
Dosage form: CAPSULE, GELATIN COATED
Route: ORAL
Labeler: Validus Pharmaceuticals LLC
Application: NDA017962
Marketing category: NDA
Marketing start: 2014-04-28
Marketing end: 0000-00-00
Substance: BROMOCRIPTINE MESYLATE
Active strength: 5 mg/1
Pharmacologic classes: Ergot Derivative [EPC],Ergolines [CS]
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	30698-201		I	Inactivated by FDA	2026-08-03
excluded package	package	30698-201	30698-201-01	I	Inactivated by FDA	2026-08-03
excluded package	package	30698-201	30698-201-30	I	Inactivated by FDA	2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 27 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	30698-201-30	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	30698-201-01	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	30698-201-30	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	30698-201-01	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	30698-201-30	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	30698-201-01	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	30698-201-30	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	30698-201-01	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	30698-201-30	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	30698-201-01	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	30698-201-30	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	30698-201-01	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	30698-201-01	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	30698-201-30	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	30698-201-01	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	30698-201-30	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	30698-201-01	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	30698-201-30	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N017962-001	PARLODEL	BROMOCRIPTINE MESYLATE	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982
N017962-002	PARLODEL	BROMOCRIPTINE MESYLATE	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD	1982-03-01

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
N017962-001	AB
N017962-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N017962-002	PARLODEL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD	1982-03-01	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N017962-002	PARLODEL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD	1982-03-01	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N017962-002	PARLODEL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD	1982-03-01	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N017962-002	PARLODEL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD	1982-03-01	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N017962-002	PARLODEL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD	1982-03-01	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N017962-002	PARLODEL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD	1982-03-01	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N017962-002	PARLODEL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD	1982-03-01	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N017962-002	PARLODEL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD	1982-03-01	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N017962-002	PARLODEL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD	1982-03-01	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N017962-002	PARLODEL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD	1982-03-01	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N017962-002	PARLODEL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD	1982-03-01	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N017962-002	PARLODEL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD	1982-03-01	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N017962-002	PARLODEL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD	1982-03-01	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N017962-002	PARLODEL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD	1982-03-01	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N017962-002	PARLODEL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD	1982-03-01	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N017962-002	PARLODEL	EQ 5MG BASE	CAPSULE / ORAL	AB	RLD	1982-03-01	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N017962-002	PARLODEL	EQ 5MG BASE	CAPSULE / ORAL	AB	RLD	1982-03-01	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N017962-002	PARLODEL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	CAPSULE / ORAL	AB	RLD	1982-03-01	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N017962-002	PARLODEL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE / ORAL	AB	RLD	1982-03-01	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N017962-001	PARLODEL	EQ 2.5MG BASE	TABLET / ORAL	AB	RLD, Approved before 1982		`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N017962-002	PARLODEL	EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons	CAPSULE / ORAL	AB	RLD	1982-03-01	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N017962-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N017962-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N017962-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N017962-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N017962-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N017962-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N017962-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N017962-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N017962-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N017962-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N017962-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N017962-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N017962-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N017962-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N017962-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N017962-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N017962-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N017962-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N017962-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N017962-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N017962-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N017962-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N017962-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N017962-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N017962-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N017962-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N017962-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N017962-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N017962-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N017962-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N017962-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N017962-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N017962-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N017962-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N017962-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N017962-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N017962-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N017962-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N017962-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N017962-002	AB	1	`782e0a99824c…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
90f4f2b3-d032-9eaf-93c5-f165b5a4c90e	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
30698-201-01	2025-01-30	Parlodel Capsules and Tablets
30698-201-30	2025-01-30	Parlodel Capsules and Tablets
30698-201-01	2023-02-27	Parlodel Capsules and Tablets
30698-201-30	2023-02-27	Parlodel Capsules and Tablets
30698-201-01	2023-01-30	Parlodel Capsules and Tablets
30698-201-30	2023-01-30	Parlodel Capsules and Tablets

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
30698-201-01	Parlodel	100 in 1 BOTTLE	CAPSULE, GELATIN COATED	100		11
30698-201-30	Parlodel	30 in 1 BOTTLE	CAPSULE, GELATIN COATED	30		11

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
30698-201-01	EA - Each	30698-201	46af5736-8b27-40c4-9300-2d871fb4295d	1	2017-03-06
30698-201-30	EA - Each	30698-201	c29b2608-adc8-4e2d-af50-9b9d925da849	1	2017-03-06

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
BROMOCRIPTINE MESYLATE	ACTIVE INGREDIENT	FFP983J3OD	PARLODEL (BROMOCRIPTINE MESYLATE) TABLET PARLODEL (BROMOCRIPTINE MESYLATE) CAPSULE, GELATIN COATED [VALIDUS PHARMACEUTICALS LLC]	4
BROMOCRIPTINE	ACTIVE MOIETY	3A64E3G5ZO	PARLODEL (BROMOCRIPTINE MESYLATE) TABLET PARLODEL (BROMOCRIPTINE MESYLATE) CAPSULE, GELATIN COATED [VALIDUS PHARMACEUTICALS LLC]	4
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	PARLODEL (BROMOCRIPTINE MESYLATE) TABLET PARLODEL (BROMOCRIPTINE MESYLATE) CAPSULE, GELATIN COATED [VALIDUS PHARMACEUTICALS LLC]	4
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	PARLODEL (BROMOCRIPTINE MESYLATE) TABLET PARLODEL (BROMOCRIPTINE MESYLATE) CAPSULE, GELATIN COATED [VALIDUS PHARMACEUTICALS LLC]	4
GELATIN	INACTIVE INGREDIENT	2G86QN327L	PARLODEL (BROMOCRIPTINE MESYLATE) TABLET PARLODEL (BROMOCRIPTINE MESYLATE) CAPSULE, GELATIN COATED [VALIDUS PHARMACEUTICALS LLC]	4
ISOPROPYL ALCOHOL	INACTIVE INGREDIENT	ND2M416302	PARLODEL (BROMOCRIPTINE MESYLATE) TABLET PARLODEL (BROMOCRIPTINE MESYLATE) CAPSULE, GELATIN COATED [VALIDUS PHARMACEUTICALS LLC]	4
LACTOSE	INACTIVE INGREDIENT	J2B2A4N98G	PARLODEL (BROMOCRIPTINE MESYLATE) TABLET PARLODEL (BROMOCRIPTINE MESYLATE) CAPSULE, GELATIN COATED [VALIDUS PHARMACEUTICALS LLC]	4
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	PARLODEL (BROMOCRIPTINE MESYLATE) TABLET PARLODEL (BROMOCRIPTINE MESYLATE) CAPSULE, GELATIN COATED [VALIDUS PHARMACEUTICALS LLC]	4
MALEIC ACID	INACTIVE INGREDIENT	91XW058U2C	PARLODEL (BROMOCRIPTINE MESYLATE) TABLET PARLODEL (BROMOCRIPTINE MESYLATE) CAPSULE, GELATIN COATED [VALIDUS PHARMACEUTICALS LLC]	4
POVIDONES	INACTIVE INGREDIENT	FZ989GH94E	PARLODEL (BROMOCRIPTINE MESYLATE) TABLET PARLODEL (BROMOCRIPTINE MESYLATE) CAPSULE, GELATIN COATED [VALIDUS PHARMACEUTICALS LLC]	4
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	PARLODEL (BROMOCRIPTINE MESYLATE) TABLET PARLODEL (BROMOCRIPTINE MESYLATE) CAPSULE, GELATIN COATED [VALIDUS PHARMACEUTICALS LLC]	4
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	PARLODEL (BROMOCRIPTINE MESYLATE) TABLET PARLODEL (BROMOCRIPTINE MESYLATE) CAPSULE, GELATIN COATED [VALIDUS PHARMACEUTICALS LLC]	4
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	PARLODEL (BROMOCRIPTINE MESYLATE) TABLET PARLODEL (BROMOCRIPTINE MESYLATE) CAPSULE, GELATIN COATED [VALIDUS PHARMACEUTICALS LLC]	4
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	PARLODEL (BROMOCRIPTINE MESYLATE) TABLET PARLODEL (BROMOCRIPTINE MESYLATE) CAPSULE, GELATIN COATED [VALIDUS PHARMACEUTICALS LLC]	4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
30698-201	PARLODEL (BROMOCRIPTINE MESYLATE) TABLET PARLODEL (BROMOCRIPTINE MESYLATE) CAPSULE, GELATIN COATED [VALIDUS PHARMACEUTICALS LLC]	11	Legacy NDC, 2 package rows	20231215_fc2a08dd-4fb6-4ac4-9082-f99552fae25c.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Bromocriptine Mesylate	BROMOCRIPTINE MESYLATE	ANI Pharmaceuticals, Inc.	17f3a343-1782-4799-95ba-31dfe93be2cf	2026-07-27	Warnings, Adverse reactions	Exact identifier application applno (NDA): 017962 application number: NDA017962
Bromocriptine Mesylate	BROMOCRIPTINE MESYLATE	American Health Packaging	ddd292a5-72af-448f-8b88-cc4fd99ec783	2026-06-12	Warnings, Adverse reactions	Exact identifier application applno (NDA): 017962 application number: NDA017962

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
FFP983J3OD	BROMOCRIPTINE MESYLATE	22260-51-1	BROMOCRIPTINE MESYLATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
197411	bromocriptine mesylate 2.5 MG Oral Tablet	PSN	fc2a08dd-4fb6-4ac4-9082-f99552fae25c	11
197412	bromocriptine mesylate 5 MG Oral Capsule	PSN	fc2a08dd-4fb6-4ac4-9082-f99552fae25c	11
105446	Parlodel 2.5 MG Oral Tablet	PSN	fc2a08dd-4fb6-4ac4-9082-f99552fae25c	11
105050	Parlodel 5 MG Oral Capsule	PSN	fc2a08dd-4fb6-4ac4-9082-f99552fae25c	11
105446	bromocriptine 2.5 MG Oral Tablet [Parlodel]	SBD	fc2a08dd-4fb6-4ac4-9082-f99552fae25c	11
105050	bromocriptine 5 MG Oral Capsule [Parlodel]	SBD	fc2a08dd-4fb6-4ac4-9082-f99552fae25c	11
197411	bromocriptine 2.5 MG Oral Tablet	SCD	fc2a08dd-4fb6-4ac4-9082-f99552fae25c	11
197412	bromocriptine 5 MG Oral Capsule	SCD	fc2a08dd-4fb6-4ac4-9082-f99552fae25c	11
197411	bromocriptine (as bromocriptine mesylate) 2.5 MG Oral Tablet	SY	fc2a08dd-4fb6-4ac4-9082-f99552fae25c	11
197412	bromocriptine 5 MG (as bromocriptine mesylate 5.74 MG) Oral Capsule	SY	fc2a08dd-4fb6-4ac4-9082-f99552fae25c	11
105446	Parlodel 2.5 MG Oral Tablet	SY	fc2a08dd-4fb6-4ac4-9082-f99552fae25c	11
105050	Parlodel 5 MG Oral Capsule	SY	fc2a08dd-4fb6-4ac4-9082-f99552fae25c	11
105446	Parlodel SnapTabs 2.5 MG Oral Tablet	SY	fc2a08dd-4fb6-4ac4-9082-f99552fae25c	11

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
30698-201-01	30698020101	100 CAPSULE, GELATIN COATED in 1 BOTTLE (30698-201-01)	2014-04-28	0000-00-00	No	No	Current
30698-201-30	30698020130	30 CAPSULE, GELATIN COATED in 1 BOTTLE (30698-201-30)	2014-04-28	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Parlodel Capsules and Tablets	Validus Pharmaceuticals LLC	2023-12-15	HUMAN PRESCRIPTION DRUG LABEL	11